Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,204 | 6,810 | N/A | N/A |
| Depreciation Amortization | 230 | 200 | N/A | N/A |
| Income taxes - deferred | 398 | N/A | N/A | N/A |
| Accounts receivable | 936 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -362 | N/A | N/A | N/A |
| Other Working Capital | 4,635 | 750 | N/A | N/A |
| Other Operating Activity | -370 | 1,180 | 0 | 0 |
| Operating Cash Flow | $1,261 | $8,940 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,044 | -990 | N/A | N/A |
| Other Investing Activity | -198 | -190 | 0 | 0 |
| Investing Cash Flow | $-1,242 | $-1,180 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 428 | N/A | N/A | N/A |
| Common Stock Repurchased | -14,788 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -4,930 | 0 | 0 |
| Financing Cash Flow | $-14,361 | $-4,930 | $N/A | $N/A |
| Beginning Cash Position | 28,332 | 25,490 | N/A | N/A |
| End Cash Position | 13,991 | 28,330 | N/A | N/A |
| Net Cash Flow | $-14,341 | $2,830 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 1,261 | 8,940 | N/A | N/A |
| Capital Expenditure | -1,044 | N/A | N/A | N/A |
| Free Cash Flow | 217 | 8,940 | 0 | 0 |